Sandoz is to appeal a court decision preventing it from launching a cheaper biosimilar competitor to Amgen’s Enbrel (etanercept) inflammatory diseases drug in the US, three years after approval ...

New prices negotiated this year between CMS and drug companies will be applicable ... and a 67% discount for Enbrel (etanercept, Amgen). Those price reductions are set to take effect in 2026.

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Sales of cholesterol-lowering medication Repatha rose 45% to $606 million, while sales of arthritis drug Enbrel were flat at $1 billion. In the rare disease space, Amgen's sales of thyroid eye ...

State leaders are reviving talk of importing prescription drugs from Canada, even as US drugmakers and health-care attorneys ...

Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, are quickly slapped down in the courts. Some, ...

As a result, 10 popular drugs covered under Medicare Part D (the prescription drug benefit) were selected for price ...

The appeals court ruling blocks Sandoz from producing a biosimilar of Enbrel (etanercept) until 2029, more than thirty years after it was first approved. Sandoz, which is the biosimilars and ...

Donald Trump is executing a shock-and-awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...

For Aiken, that means no more delaying home repairs or skipping doses of the common but pricey arthritis drug Enbrel. AIKEN: I'm not proud to say this, but there were times when I would delay ...

Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals that distract from ...